INSIGHTS ON UPSTREAM MANUFACTURING
-
InSiliCHO: Modeling Cell Line Dynamics For Process Development
Modeling and simulation can be a powerful tool for bioprocess design. Find out how you can utilize an open source implementation for in silico simulation of CHO.
-
Sf9 Cell Suspension Culture In Corning® Insect Cell Serum-Free Medium
Explore the information gathered when the growth of Sf9 insect cells was studied in three different mediums.
-
Vero Cell Culture In Corning® Dry Powder Vero Serum-free Medium
This study compares a serum-free medium to other commercially available pre-hydrated media to measure it's effectiveness in supporting the culture of adherent Vero cells.
-
Culturing And Characterizing Organoids And Cancer Spheroids
Discover techniques for generating, maintaining, and performing high-throughput analysis of organoids and other 3D culture systems that are essential for cutting-edge regenerative medicine research.
-
Optimizing Perfusion Parameters For Intensified Production Of CAR-T Cells4/18/2024
Achieving therapeutic doses in CAR-T cell therapies represents the longest phase of manufacturing. In this webinar, we explore scalable expansion processes designed to help meet growing demand.
-
Achieving a 21-Fold Increase in Plasmids4/17/2024
This study compares a plasmid production process using differing shaker flasks to assess the cultivation similarities and contrasts, as well as total plasmid yields after plasmid purification.
-
Optimizing Human iPSC Aggregate And Organoid Production For Bioprinting4/17/2024
This study aimed to identify the optimal cell culture conditions to yield high cell density and maintain high cell viability with consistent aggregate morphology and pluripotency marker expression.
-
Tips For Viral Vector Production4/16/2024
Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.
UPSTREAM MANUFACTURING SOLUTIONS
-
Evaluate your clones, strains, and viral constructs in our bioreactors with flexible scale out.
Benefits
Select the best clone by evaluating larger experimental cohorts
Make the most informed, data-driven selection by leveraging our fleet of 250mL and 5L Culture bioreactors to screen your clones, strains and viral constructs.
Defer your capital equipment spend
Evaluate your clones, strains and viral constructs without the need for new capital equipment.
Transparent, real-time data provided by a team of experts
Painless technology transfer with live data relayed via our cloud-connected systems. We have >95% success rate with >22,000 runs successfully executed.
-
Gain access to Culture bioreactors when you need rapid overflow experimental capacity.
Benefits
Progress studies faster
Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.
Stay agile in your capacity planning
Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.
Eliminate your capital equipment spend
Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.
-
Assess your process in scale-down bioreactors that allow for increased model curvature and variables in your process DOEs.
-
Discover a cutting-edge approach that enables you to screen for glycans at every stage of CLD and streamline your workflow.
-
Discover an assay that leverages the power of whole genome sequencing and expert bioinformatics to deliver a faster, all-in-one solution for a comprehensive testing package.